Table 3.
Correlation of INPP5A protein expression with different clinicopathological parameters of ESCC patients
| Parameters | Protein | p value | ||||
|---|---|---|---|---|---|---|
| Negative | Low | High | ||||
| Gender | ||||||
| Male | 17 | 9 | 6 | 0.357 | ||
| Female | 13 | 6 | 5 | |||
| Grade of differentiation | ||||||
| P.D. | 8 | 2 | 0 | 0.466 | ||
| M.D. | 14 | 11 | 9 | |||
| W.D. | 8 | 1 | 3 | |||
| Tumor location | ||||||
| Lower | 14 | 4 | 5 | 0.438 | ||
| Middle | 15 | 10 | 7 | |||
| Upper | 1 | 0 | 0 | |||
| Depth of tumor invasion | ||||||
| T1 | 2 | 0 | 1 | 0.795 | ||
| T2 | 6 | 1 | 1 | |||
| T3 | 22 | 13 | 10 | |||
| LNM | 15 | 7 | 9 | 0.174 | ||
| No metastasis | 15 | 7 | 3 | |||
| Node metastasis | 0 | 0 | 1 | |||
| Stage of tumor progression | ||||||
| I | 0 | 0 | 1 | 0.872 | ||
| IIa | 14 | 14 | 8 | |||
| IIb | 4 | 4 | 0 | |||
| III | 12 | 12 | 3 | |||
| IV | 0 | 0 | 0 | |||
P.D., poorly differentiated; M.D., moderately differentiated; W.D., well differentiated